DARGAN CHARLES K 4
4 · BIOLARGO, INC. · Filed Oct 8, 2020
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
DARGAN CHARLES K
Chief Financial Officer
Transactions
- Award
Option to purchase common stock
2020-10-08+50,000→ 3,460,786 totalExercise: $0.15From: 2020-10-08Exp: 2030-09-30→ Common stock (50,000 underlying) - Award
Option to purchase common stock
2020-10-08+2,500→ 3,610,786 totalExercise: $0.15From: 2020-10-08Exp: 2030-09-30→ Common stock (2,500 underlying)
Footnotes (4)
- [F1]This Option was granted to Reporting Person to replace options to purchase 10,000 shares of Issuer's common stock that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and the Issuer's current stock price, pursuant to a plan adopted by the Issuer's Compensation Committee.
- [F2]This amount reflects, in addition to the reported option grant, the expiration on September 30, 2020, of an option to purchase an 10,000 shares of common stock.
- [F3]This Option was granted to Reporting Person to replace options to purchase 200,000 shares of Issuer's common stock that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and the Issuer's current stock price, pursuant to a plan adopted by the Issuer's Compensation Committee.
- [F4]This amount reflects, in addition to the reported option grant, the expiration on August 5, 2020, of an option to purchase an 200,000 shares of common stock.